![Starpharma Holdings Limited](/images/logos/30190en.gif)
The Company's lead pharmaceutical development product is VivaGel(R) (SPL7013 Gel), a vaginal microbicide designed to prevent the transmission of STIs, including HIV and genital herpes.
![](/images/buts/heroes_alert_button.jpg)
Starpharma Holdings Limited (ASX: SPL) - 2006 AGM CEO's Address - Dr Jackie Fairley, CEO; Boardroomradio is pleased to announce that Starpharma Holdings Limited (ASX: SPL) has published an audio file.
Starpharma Holdings Limited (ASX: SPL) - To Acquire Dendritic Nanotechnologies Inc - Dr Jackie Fairley, CEO; Boardroomradio is pleased to announce that Starpharma Holdings Limited (ASX: SPL) has published an audio file.
Starpharma Holdings Limited (ASX: SPL) - VivaGel IND for Genital Herpes Trial clears US FDA - Dr Jackie Fairley, CEO; Boardroomradio is pleased to announce that Starpharma Holdings Limited (ASX: SPL) has published an audio file.
STARPHARMA HOLDINGS LIMITED (ASX: SPL) - Update on lead product VivaGel - Ms Jackie Fairley, Chief Operating Officer; Boardroomradio is pleased to announce that STARPHARMA HOLDINGS LIMITED (ASX: SPL)
STARPHARMA HOLDINGS LIMITED (ASX: SPL) - Market Briefing - Dr John Raff, MD & CEO; Boardroomradio is pleased to announce that STARPHARMA HOLDINGS LIMITED (ASX: SPL) has published an audio file. The fo